𝗔𝗔𝗖𝗥 𝟮𝟬𝟮𝟱 𝗺𝗮𝘆 𝗯𝗲 𝗼𝘃𝗲𝗿, 𝗯𝘂𝘁 𝘁𝗵𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲! Evotec’s team was proud to present groundbreaking scientific posters showcasing our latest advancements in oncology research. From innovative drug discovery approaches to cutting-edge translational models, our work is driving the future of cancer therapeutics. If you missed us at the event, you can still explore our findings! 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝗼𝘂𝗿 #𝗔𝗔𝗖𝗥𝟮𝟱 𝗽𝗼𝘀𝘁𝗲𝗿𝘀 𝗲𝗻𝘁𝗶𝘁𝗹𝗲𝗱, Mice humanized for the immune system as validated tool for therapeutic antibody development, and our second poster, A Novel CD2-Targeted Costimulatory Bispecific Antibody Platform for Enhancing CD3 T Cell Engager-Based Cancer Immunotherapy here- https://hubs.ly/Q03lNwKd0 𝗔 𝗵𝘂𝗴𝗲 𝘁𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝘁𝗼 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 who visited our presentations, engaged in discussions, and continues to push the boundaries of oncology innovation with us. Let’s keep the conversation going! What were your key takeaways from AACR? #OncologyResearch #CancerTherapeutics
